Advertisement Ecron Acunova Launches Direct Operation In Russia - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Ecron Acunova Launches Direct Operation In Russia

To strengthen clinical trials in the region

Ecron Acunova, a full-service clinical research organization (CRO), has opened a new office in Moscow, Russia in October 2009. Galyna Andriyko has been named as General Manager. She will lead the development of the Russian office operations.

Antal Hajos, managing director and CEO of Ecron Acunova, said: “This is another key step for Ecron Acunova in creating a unique platform for clients to fully benefit from the strengths of global reach with local expertise. Russia has substantial unexplored capabilities. With its 141 million population and well recognised experience in clinical trials, Russia allows high recruitment rates, low drop-out rates and high quality data, to be obtained by dedicated medical professionals. With Mrs Andriyko’s expertise, we look forward to strengthening clinical trials in this region.”

Across Europe, Ecron Acunova covers 14 countries. In CEE Ecron Acunova has offices in the Czech Republic (Prague), Poland (Warsaw) and Ukraine (Kyiv).